Transformative Impact of Nanocarrier‐Mediated Drug Delivery: Overcoming Biological Barriers and Expanding Therapeutic Horizons
Small Science · 2024-11 · 4 (11)
DOI: 10.1002/smsc.202400280 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small Science, online erschienen am 17.09.2024. Verfasst von Minhye Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Graduate Program in Advanced Convergence Technology and Science Jeju National University Jeju-si Jeju Special Self-Governing Provin…. Die Arbeit wurde bisher 97-mal zitiert (Crossref) und nennt 282 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Advancing therapeutic progress is centered on developing drug delivery systems (DDS) that control therapeutic molecule release, ensuring precise targeting and optimal concentrations. Targeted DDS enhances treatment efficacy and minimizes off‐target effects, but struggles with drug degradation. Over the last three decades, nanopharmaceuticals have evolved from laboratory concepts into clinical products, highlighting the profound impact of nanotechnology in medicine. Despite advancements, the effective delivery of therapeutics remains challenging because of biological barriers. Nanocarriers offer a solution with a small size, high surface‐to‐volume ratios, and customizable properties. These systems address physiological and biological challenges, such as shear stress, protein adsorption, and quick clearance. They allow targeted delivery to specific tissues, improve treatment outcomes, and reduce adverse effects. Nanocarriers exhibit controlled release, decreased degradation, and enhanced efficacy. Their size facilitates cell membrane penetration and intracellular delivery. Surface modifications increase affinity for specific cell types, allowing precise treatment delivery. This study also elucidates the potential integration of artificial intelligence with nanoscience to innovate future nanocarrier systems.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Interdisciplinary Graduate Program in Advanced Convergence Technology and Science Jeju National University Jeju-si Jeju Special Self-Governing Province 63243 Republic of Korea.
- Department of Animal Biotechnology Faculty of Biotechnology College of Applied Life Sciences Jeju National University Jeju-si Jeju Special Self-Governing Province 63243 Republic of Korea.
- School of Chemistry and Chemical Engineering Frontiers Science Center for Transformative Molecules Shanghai Jiao Tong University Shanghai 200240 P. R. China.
- Bio-Health Materials Core-Facility Center Jeju National University Jeju-si 63243 Republic of Korea.
- Practical Translational Research Center Jeju National University Jeju-si 63243 Republic of Korea.
ORCID-Profile: Mrinmoy Ghosh, Young-Ok Son
Förderung
- National Research Foundation of Korea
Zitieren
APA
Kim, M., Shin, M., Zhao, Y., Ghosh, M., & Son, Y. O. (2024). Transformative Impact of Nanocarrier‐Mediated Drug Delivery: Overcoming Biological Barriers and Expanding Therapeutic Horizons. Small Science, 4(11). https://doi.org/10.1002/smsc.202400280
Vancouver
Kim M, Shin M, Zhao Y, Ghosh M, Son YO. Transformative Impact of Nanocarrier‐Mediated Drug Delivery: Overcoming Biological Barriers and Expanding Therapeutic Horizons. Small Science. 2024;4(11). doi:10.1002/smsc.202400280
BibTeX
@article{Kim2024,
author = {Kim, Minhye and Shin, Myeongyeon and Zhao, Yaping and Ghosh, Mrinmoy and Son, Young-Ok},
title = {Transformative Impact of Nanocarrier‐Mediated Drug Delivery: Overcoming Biological Barriers and Expanding Therapeutic Horizons},
journal = {Small Science},
year = {2024},
volume = {4},
number = {11},
doi = {10.1002/smsc.202400280}
}
EUVIMED